Kissei

Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:[1]

Kissei Pharmaceutical
ISINJP3240600001
IndustryPharmaceutical products, therapeutic and care foods
FoundedAugust 9, 1946 (1946-08-09)
Headquarters
Matsumoto, Nagano
,
Japan
Key people
Mutsuo Kanzawa (CEO)
Number of employees
1504
Websitewww.kissei.co.jp/e_contents/

In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immumotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China.[2]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.